 |
Our Company
Our People Services Industries Careers |
|
Leadership Board of Directors
|
Anwar Matin Chief Executive Officer (CEO) Anwar Matin offers exceptional experience and in-depth expertise in banking, finance and M&A advisory services, acquired over a thirty years career with KPMG. He moved to Middle East in 1975 and rose to become a partner in 1987. With KPMG he held various Senior Positions including Head of Corporate Finance UAE and lower gulf, Managing Partner Oman and headed consulting businesses in the UAE and the lower gulf for several years. He also represented KPMG Lower Gulf on the Managing Board of the Consultancy Practice in Saudi Arabia. In 2000 he left KPMG and joined his family in Canada. He led a boutique operation dedicated to venture capital financing in Toronto, Ontario. Anwar Matin has more recently acquired interests in technology BPO and other services businesses in Pakistan. He has also been engaged in setting a national distribution operation for Obus Forme Canada products in Pakistan.
Anwar Matin is a fellow of the Institute of Chartered Accountants.
|
 |
||
|
Taha Kisat Chief Operating Officer (COO) Taha Kisat comes to ECAS with over 10 years of experience in the Information Technology consulting arena for various clients in the USA. His experience amongst other things include company wide business process re-engineering, compliance programme management, project management, system design, testing and implementation of various solutions including SP implementation. His most recent experience has been in the pharmaceutical / biotech sector where he has worked with Emergent BioSolutions (the only FDA approved manufacturer of the Anthrax vaccine in the world) and Chiron (a division of Novartis Vaccines and Diagnostics). He was also associated with TAB products, where he consulted with Fortune 500 companies, such as Daimler-Chrysler, Blue Cross Blue Shield, AIG, etc; on the analysis, re-organization and deployment of solutions. In each case creating a process whereby his clients would see a ROI of less than 2 years on each solution implemented. At Chiron, he was a key part of the team responsible for obtaining FDA approval on a medical device (hardware and software) used to test blood for HIV, hepatitis, etc. At Emergent BioSolutions, Taha Kisat was responsible for maintaining the corporate IT compliance programme keeping in mind the regulations of SEC, FDA and other government oversight bodies. Taha was also part of the functional leadership team during the successful deployment of SAP at Emergent BioSolutions. During his tenure at Emergent BioSolutions, Taha has received special recognition from the US Department of Defense (DOD), for his activities towards the support of USA’s bio-defense program.
|
 |
||